Financial Statements · From SEC 10-K & 10-Q XBRL Filings
Zoetis Inc. Revenue & Financial Statements
Zoetis Inc. reported revenue of $9.5B for the fiscal year ended December 31, 2025, up 2.3% year over year, with net income of $2.7B and diluted EPS of $6.02.
- Company
- Zoetis Inc. ZTS · NYSE
- Latest fiscal year
- FY ended Dec 31, 2025
- Statements
- Income · Balance Sheet · Cash Flow — 5 fiscal years, 8 quarters
Income Statement
Annual, as reported in 10-K filings. Values in USD.
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | 7.8B | 8.1B | 8.5B | 9.3B | 9.5B |
| Cost of revenue | 2.3B | 2.5B | 2.6B | 2.7B | 2.7B |
| Gross profit | 5.5B | 5.6B | 6.0B | 6.5B | 6.8B |
| Operating income | — | — | — | — | — |
| Pretax income | 2.5B | 2.7B | 2.9B | 3.1B | 3.4B |
| Net income | 2.0B | 2.1B | 2.3B | 2.5B | 2.7B |
| Diluted EPS | 4.27 | 4.49 | 5.07 | 5.47 | 6.02 |
| EBITDA | — | — | — | — | — |
Quarterly
| USD | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.2B | 2.4B | 2.4B | 2.3B | 2.2B | 2.5B | 2.4B | 2.4B |
| Cost of revenue | 643.0M | 668.0M | 701.0M | 707.0M | 622.0M | 649.0M | 683.0M | 712.0M |
| Gross profit | 1.5B | 1.7B | 1.7B | 1.6B | 1.6B | 1.8B | 1.7B | 1.7B |
| Operating income | — | — | — | — | — | — | — | — |
| Pretax income | 747.0M | 780.0M | 874.0M | 732.0M | 810.0M | 902.0M | 887.0M | 761.0M |
| Net income | 599.0M | 624.0M | 682.0M | 581.0M | 631.0M | 718.0M | 721.0M | 603.0M |
| Diluted EPS | 1.31 | 1.37 | 1.50 | 1.29 | 1.41 | 1.61 | 1.63 | 1.37 |
| EBITDA | — | — | — | — | — | — | — | — |
Balance Sheet
Fiscal year-end snapshots. Values in USD.
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Total assets | 13.9B | 14.9B | 14.3B | 14.2B | 15.5B |
| Current assets | 6.9B | 7.5B | 6.3B | 6.0B | 6.8B |
| Cash & equivalents | — | — | — | — | — |
| Total liabilities | 9.4B | 10.5B | 9.3B | 9.5B | 12.1B |
| Current liabilities | 1.8B | 3.2B | 1.9B | 3.4B | 2.2B |
| Long-term debt | 6.6B | 6.6B | 6.6B | 5.2B | 9.0B |
| Total debt | 6.6B | 6.6B | 6.6B | 5.2B | 9.0B |
| Stockholders’ equity | 4.5B | 4.4B | 5.0B | 4.8B | 3.3B |
| Net debt | — | — | — | — | — |
Cash Flow Statement
Annual, as reported in 10-K filings. Values in USD.
| USD | FY2022 | FY2023 | FY2024 | FY2025 | FY2025 |
|---|---|---|---|---|---|
| Operating cash flow | 1.9B | 2.4B | 3.0B | — | 2.9B |
| Investing cash flow | (883.0M) | (777.0M) | (315.0M) | — | (748.0M) |
| Financing cash flow | (904.0M) | (3.1B) | (2.7B) | — | (1.9B) |
| Capital expenditure | 586.0M | 732.0M | 655.0M | — | 621.0M |
| Free cash flow | 1.3B | 1.6B | 2.3B | — | 2.3B |
| Dividends paid | — | — | — | — | — |
| Stock-based compensation | 62.0M | 60.0M | 74.0M | — | 83.0M |
Figures are parsed from SEC XBRL company facts and may be derived where issuers report year-to-date values (quarterly figures differenced; Q4 computed as FY minus Q3). Fiscal periods follow each company's fiscal calendar, not calendar years. Historical fact, not investment advice — verify with official SEC filings.
Every ZTS filing, connected
Financials beside price, insider trades, and 8-K events — with alerts the moment something new is filed.